Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
14.58
0.14 (0.97%)
At close: May 01, 2025, 3:59 PM
14.57
-0.07%
After-hours: May 01, 2025, 07:11 PM EDT
Keros Therapeutics Revenue
Keros Therapeutics reported an annual revenue of $3.55M, reflecting a 2250.99% growth. For the quarter ending December 31, 2024, Keros Therapeutics generated $3.04M in revenue.
Revenue (ttm)
$3.55M
Revenue Growth
2250.99%
Price / Sales Ratio
166.94
Revenue / Employee
$21.01K
Employees
169
Market Cap
592.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 3.55M | +2250.99% |
| Dec 31, 2023 | 151K | +Infinity% |
| Dec 31, 2022 | 0 | -100.00% |
| Dec 31, 2021 | 20.1M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |